SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
-4.26%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$642M
AUM Growth
+$642M
(-1.3%)
Cap. Flow
+$70.9M
Cap. Flow
% of AUM
11.04%
Top 10 Holdings %
Top 10 Hldgs %
47.56%
Holding
90
New
25
Increased
18
Reduced
19
Closed
18
Top Buys
| 1 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$28.8M |
| 2 |
United Therapeutics
UTHR
|
$18.8M |
| 3 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
$12.7M |
| 4 |
Enanta Pharmaceuticals
ENTA
|
$10.4M |
| 5 |
Organogenesis Holdings
ORGO
|
$9.11M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$27.9M |
| 2 |
The Beauty Health Co
SKIN
|
$19M |
| 3 |
ITMR
Itamar Medical Ltd. American Depository Shares
ITMR
|
$10.6M |
| 4 |
NovoCure
NVCR
|
$8.33M |
| 5 |
BioAtla
BCAB
|
$8.21M |
Sector Composition
| 1 | Healthcare | 91.89% |
| 2 | Financials | 1.01% |
| 3 | Consumer Staples | 0.82% |
| 4 | Real Estate | 0.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Y-mAbs Therapeutics
YMAB
$388M
| $7.58M | 1.18% | 265,700 +121,400 | +84% | +$3.46M |
|
27
Inspire Medical Systems
INSP
$2.77B
| $7.21M | 1.12% | 30,950 +9,400 | +44% | +$2.19M |
|
28
Krystal Biotech
KRYS
$4.27B
| $6.55M | 1.02% | 125,529 +58,000 | +86% | +$3.03M |
|
29
Cytosorbents Corp
CTSO
$59.2M
| $6.5M | 1.01% | +800,000 | New | +$6.5M |
|
30
AngioDynamics
ANGO
$417M
| $6.29M | 0.98% | +242,525 | New | +$6.29M |
|
31
Galapagos
GLPG
$2.07B
| $6.07M | 0.95% | +115,300 | New | +$6.07M |
|
|
ITMR
32
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $5.47M | 0.85% | 180,839 -350,000 | -66% | -$10.6M |
|
|
33
The Beauty Health Co
SKIN
$264M
| $5.25M | 0.82% | 201,994 -732,322 | -78% | -$19M |
|
|
SLGC
34
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $5.23M | 0.82% | +422,243 | New | +$5.23M |
|
35
Vanda Pharmaceuticals
VNDA
$279M
| $5.12M | 0.8% | +298,600 | New | +$5.12M |
|
36
Travere Therapeutics
TVTX
$1.56B
| $5.11M | 0.8% | +210,815 | New | +$5.11M |
|
37
Evolus
EOLS
$494M
| $4.9M | 0.76% | 642,934 +62,934 | +11% | +$480K |
|
38
Atea Pharmaceuticals
AVIR
$267M
| $4.12M | 0.64% | +117,600 | New | +$4.12M |
|
39
Assembly Biosciences
ASMB
$190M
| $3.91M | 0.61% | 1,122,000 | – | – |
|
|
PVLA
40
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $3.83M | 0.6% | +740,000 | New | +$3.83M |
|
|
CMPS
41
Compass Pathways
CMPS
$424M
| $3.82M | 0.59% | 127,743 | – | – |
|
42
Pacira BioSciences
PCRX
$1.2B
| $3.7M | 0.58% | +66,000 | New | +$3.7M |
|
|
DALS
43
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
| $3.44M | 0.54% | +350,000 | New | +$3.44M |
|
|
ARNA
44
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $3.38M | 0.53% | +56,800 | New | +$3.38M |
|
45
Xenon Pharmaceuticals
XENE
$2.98B
| $3.3M | 0.51% | 215,697 -18,000 | -8% | -$275K |
|
|
INBX
46
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $3.26M | 0.51% | 97,979 -144,810 | -60% | -$4.82M |
|
47
4D Molecular Therapeutics
FDMT
$288M
| $3.26M | 0.51% | 120,900 +20,100 | +20% | +$542K |
|
|
48
NovoCure
NVCR
$1.38B
| $3.17M | 0.49% | 27,275 -71,700 | -72% | -$8.33M |
|
49
Pulmonx
LUNG
$69.7M
| $3.15M | 0.49% | 87,612 +2,362 | +3% | +$85K |
|
|
VIVO
50
DELISTED
Meridian Bioscience Inc
VIVO
| $3.14M | 0.49% | +163,000 | New | +$3.14M |
|